The 3rd Conference on Health Research and Policy will be held at the Kigali Convention Centre on 23 and 24 May 2024. Are you a researcher? Abstract submission is open until 15 March 2024. Submit yours.

There is still time to submit your abstract for the highly anticipated Health Research and Policy Conference. The new deadline is 29 March 2029. Click on the link below to submit your abstract today 👇 rbc.gov.rw/Rwanda_Evidenc…

Malaria remains a significant global challenge. World Malaria Day is a day to recognize the tireless efforts of healthcare workers, researchers, and all involved in eliminating malaria. Let's keep the momentum towards ending malaria-Dr Eric Remera #WMD2024 #MIM2024 #PAMC2024

Today, we come together to honor progress, reflect on challenges, and reaffirm our commitment to ending the devastating impact of malaria on communities around the world. #MIM2024 , #AfricaEndingMalaria , #RBC

Research and development (R&D) has played a crucial role in malaria control and elimination efforts by driving innovation, improving existing interventions, and discovering new strategies to combat the disease. #MIM2024 , #AfricaEndingMalaria

How exercise promotes a healthy immune response, reduces inflammation, and may slow the aging process cell.com/cell-metabolis… Cell Metabolism @KentLangston

In their remarks at the #WorldMalariaDay celebration, Dr Eric Remera,PhD and Prof Evelyn Ansah, Co-Chairs of the #MIM2024 Scientific Committee, reiterated that it is an opportunity to celebrate progress, reflect on challenges and reaffirm the collective commitment to #EndMalaria.

Prof. Marcel Tanner's recognition is for his invaluable contributions to malaria research and, notably, for his efforts in strengthening capacities from local communities to higher echelons of leadership. At the #MIM2024 conference, we observed his dedication to training CHW.

Great team indeed. #MIM2024 linkedin.com/posts/mim-soci…

The third annual Health Research & Policy Conference is now underway at KCC. Over two days, policymakers, researchers, health professionals and stakeholders will forge a united front to shape the future of health in Rwanda. Don't miss the latest from #Research4Rwanda2024

In his opening remarks, Prof. Prof. Dr. Claude M. Muvunyi, DG of Rwanda Biomedical Centre, emphasised the need to bridge the gap between research and policy implementation for success. #Research4Rwanda2024

Dr Eric Remera, Division Manager of Research Innovation and Data Science, presented Rwanda's National Health Research Strategy and highlighted the importance of capacity building and the use of data science to improve the quality & effectiveness of research #Research4Rwanda2024.

This morning's plenary featured presentations from our partners, including WHO Rwanda, UNFPA Rwanda and Akagera Medicines, reinforcing the spirit of partnership and collaboration in advancing health research in Rwanda. #Research4Rwanda2024

In a dynamic panel discussion at #Research4Rwanda2024 today, experts from University of Rwanda, National Council for Science and Technology (NCST), UNFPA in Rwanda & Rwanda Social Security Board explored best practices in the research ecosystem, gaps and opportunities in health research, and key recommendations for collaboration.

Eric Remera,PhD sharing Rwanda experience in clinical trials and current situation( challenges&Solutions) Rwanda Biomedical Centre #ConductingClinicalTrialsinAfrica #RwandaContext #GHRT

Today, RBC in partnership with GOAL3 - We All Health and Expertise France presented the findings from the study “Emergency and Critical Care Assessment (ECCA) for paediatric patients in Rwanda” The findings from the study provides a comprehensive assessment of the current state of

Just published "How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak" A powerful example of outbreak-ready research leadership. nature.com/articles/s4154… #RBC , #CEPI, #IQVIA

HIV Care in Resource Limited Settings clinicaloptions.com/activities/inf…

In 2024, Marburg virus disease was detected in Rwanda. A large-scale public health response was able to control the outbreak. Ultimately, 66 laboratory-confirmed cases were identified, largely in two urban hospitals. Full study from the Rwanda MVD Outbreak Response Team:

One year later, our NEJM study (out today) reports how science-guided detection & rapid action stopped Rwanda’s first Marburg outbreak in weeks, achieving the lowest recorded fatality 👉 nejm.org/doi/full/10.10…